Go Pro

Design Therapeutics (DSGN) Institutional Ownership

Design Therapeutics logo
$15.09 -0.05 (-0.33%)
As of 02:32 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Design Therapeutics (NASDAQ:DSGN)

Current
Institutional Ownership
Percentage
56.64%
Number of
Institutional Buyers
(last 12 months)
59
Total
Institutional Inflows
(last 12 months)
$173.48M
Number of
Institutional Sellers
(last 12 months)
22
Total
Institutional Outflows
(last 12 months)
$30.42M
Get DSGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Design Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

DSGN Institutional Buying and Selling by Quarter

Design Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/24/2026 California State Teachers Retirement System4,847$70K0.0%+275.2%0.008%
8/23/2026 Frazier Life Sciences Management L.P.1,809,854$26.19M0.6%N/A2.892%
8/20/2026 Susquehanna Fundamental Investments LLC12,553$182K0.0%N/A0.020%
8/19/2026 Wellington Management Group LLP19,400$281K0.0%N/A0.031%
8/18/2026 Public Employees Retirement System of Ohio20,700$300K0.0%N/A0.033%
8/17/2026 Almitas Capital LLC1,026,893$14.86M3.6%N/A1.641%
8/17/2026 Corient Private Wealth LP27,169$393K0.0%N/A0.043%
8/17/2026 Bank of America Corp DE43,728$633K0.0%N/A0.070%
8/15/2026 Trails Edge Capital Partners LP2,001,282$28.96M0.0%N/A3.198%
8/15/2026 Elmind Capital LP107,900$1.56M0.0%N/A0.172%
8/15/2026 J. Goldman & Co LP176,770$2.56M0.1%N/A0.282%
8/14/2026 Canada Pension Plan Investment Board32,600$472K0.0%N/A0.052%
8/14/2026 Legal & General Group Plc2,987$43K0.0%N/A0.005%
8/14/2026 Algert Global LLC296,085$4.28M0.1%+44.6%0.473%
8/7/2026 BlackRock Inc.2,660,024$38.49M0.0%N/A4.251%
8/7/2026 Deutsche Bank AG30,613$443K0.0%N/A0.049%
8/6/2026 Bank of New York Mellon Corp92,069$1.33M0.0%N/A0.147%
8/6/2026 State of Wyoming2,566$37K0.0%N/A0.004%
8/6/2026 GSA Capital Partners LLP10,328$149K0.0%N/A0.017%
5/19/2026 Bank of America Corp DE23,264$248K0.0%-15.2%0.037%
5/18/2026 ADAR1 Capital Management LLC10,000$106K0.0%N/A0.016%
5/18/2026 Royal Bank of Canada11,366$121K0.0%+1,681.5%0.018%
5/16/2026 Quantinno Capital Management LP14,128$150K0.0%N/A0.023%
5/14/2026 Renaissance Technologies LLC408,200$4.34M0.0%+42.2%0.654%
5/14/2026 Public Employees Retirement System of Ohio15,193$162K0.0%+114.2%0.024%
5/14/2026 Sei Investments Co.133,203$1.42M0.0%+152.6%0.213%
5/8/2026 Baader Bank Aktiengesellschaft12,792$136K0.0%-36.0%0.020%
5/7/2026 Dimensional Fund Advisors LP431,840$4.59M0.0%+45.0%0.691%
5/7/2026 AlphaCentric Advisors LLC21,231$226K0.2%+4.8%0.034%
5/5/2026 Bank of New York Mellon Corp79,645$847K0.0%-6.3%0.128%
4/25/2026 Strs Ohio44,700$476K0.0%+77.4%0.072%
3/9/2026 Corient Private Wealth LLC26,965$253K0.0%N/A0.047%
2/23/2026 Virtu Financial LLC22,651$212K0.0%N/A0.040%
2/19/2026 Invesco Ltd.305,757$2.87M0.0%+1,995.8%0.537%
2/19/2026 Corient Private Wealth LLC26,965$253K0.0%N/A0.047%
2/18/2026 XTX Topco Ltd35,284$331K0.0%+197.3%0.062%
2/18/2026 Millennium Management LLC180,866$1.70M0.0%+162.8%0.318%
2/18/2026 Elmind Capital LP207,900$1.95M0.6%N/A0.365%
2/18/2026 Engineers Gate Manager LP14,012$131K0.0%N/A0.025%
2/18/2026 Baker BROS. Advisors LP2,233,099$20.95M0.1%+30.4%3.920%
Congress Just Opened the Floodgates (Ad)

The House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial technology framework in US history. JPMorgan, Citi, Bank of America and Wells Fargo are building a shared next generation payment network targeting 2027, and the DTCC just completed its first live production trades on the new system. Senior analyst Andy Howard breaks down the asset at the center of this shift in a free report.tc pixel

Get the free report before the new financial grid launches this fall.
2/18/2026 Bridgeway Capital Management LLC78,500$736K0.0%-58.3%0.138%
2/18/2026 9823 Capital L.P.19,197$180K0.1%N/A0.034%
2/17/2026 Logos Global Management LP2,500,000$23.45M1.4%-31.6%4.389%
2/17/2026 RA Capital Management L.P.1,461,381$13.71M0.1%+207.2%2.566%
2/17/2026 Trexquant Investment LP99,967$938K0.0%N/A0.176%
2/17/2026 Public Employees Retirement System of Ohio7,093$67K0.0%N/A0.012%
2/17/2026 Diadema Partners LP100,320$941K0.2%N/A0.176%
2/17/2026 Russell Investments Group Ltd.25,234$237K0.0%+295.7%0.044%
2/17/2026 State of Wisconsin Investment Board50,657$475K0.0%+87.2%0.089%
2/17/2026 Persistent Asset Partners Ltd34,989$328K0.1%N/A0.061%
2/16/2026 Squarepoint Ops LLC46,142$433K0.0%N/A0.081%
2/16/2026 Mariner LLC12,822$120K0.0%-20.3%0.023%
2/16/2026 Frazier Life Sciences Management L.P.521,000$4.89M0.1%-73.3%0.915%
2/16/2026 Kennedy Capital Management LLC50,023$469K0.0%+70.1%0.088%
2/16/2026 Barclays PLC87,060$817K0.0%-1.3%0.153%
2/13/2026 Marshall Wace LLP225,528$2.12M0.0%N/A0.396%
2/13/2026 Vivo Capital LLC1,612,903$15.13M1.0%N/A2.832%
2/13/2026 Jacobs Levy Equity Management Inc.194,611$1.83M0.0%N/A0.342%
2/13/2026 Charles Schwab Investment Management Inc.236,863$2.22M0.0%-4.5%0.416%
2/13/2026 State Street Corp647,636$6.08M0.0%+2.1%1.137%
2/13/2026 Wells Fargo & Company MN26,786$251K0.0%+46.2%0.047%
2/12/2026 MetLife Investment Management LLC15,249$143K0.0%+47.8%0.027%
2/12/2026 Renaissance Technologies LLC287,100$2.69M0.0%+4.7%0.504%
2/12/2026 Dimensional Fund Advisors LP297,921$2.80M0.0%+6.5%0.523%
2/12/2026 AlphaCentric Advisors LLC20,262$190K0.2%N/A0.036%
2/12/2026 Informed Momentum Co LLC78,949$741K0.1%N/A0.139%
2/12/2026 Alps Advisors Inc.46,771$439K0.0%N/A0.082%
2/12/2026 Nuveen LLC125,260$1.18M0.0%-5.8%0.220%
2/11/2026 Deutsche Bank AG15,541$146K0.0%N/A0.027%
2/10/2026 Goldman Sachs Group Inc.270,654$2.54M0.0%+3.5%0.475%
2/10/2026 AXQ Capital LP11,728$110K0.0%N/A0.021%
2/10/2026 Caz Investments LP3,500$33K0.1%-30.0%0.006%
2/9/2026 Geode Capital Management LLC679,590$6.38M0.0%-2.3%1.193%
2/5/2026 Baader Bank Aktiengesellschaft20,000$188K0.0%N/A0.035%
2/2/2026 Strs Ohio25,200$236K0.0%+11.5%0.044%
1/30/2026 Torren Management LLC2,820$26K0.0%N/A0.005%
1/21/2026 Palumbo Wealth Management LLC69,377$651K0.2%+33.2%0.122%
1/1/2026 JPMorgan Chase & Co.23,221$175K0.0%+26.7%0.041%
11/17/2025 Woodline Partners LP612,712$4.61M0.0%-21.2%1.076%
11/17/2025 Susquehanna International Group LLP14,023$106K0.0%-72.6%0.025%
11/17/2025 RA Capital Management L.P.475,699$3.58M0.0%N/A0.835%
11/17/2025 Millennium Management LLC68,823$518K0.0%N/A0.121%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,724$81K0.0%-40.3%0.019%
11/17/2025 Citadel Advisors LLC554,020$4.17M0.0%-34.1%0.973%
11/14/2025 Two Sigma Investments LP59,237$446K0.0%-33.7%0.104%
11/13/2025 Kennedy Capital Management LLC29,411$221K0.0%+95.9%0.052%
11/13/2025 Russell Investments Group Ltd.6,377$48K0.0%+69.6%0.011%
11/13/2025 DLD Asset Management LP50,000$376K0.0%N/A0.088%
11/12/2025 Dimensional Fund Advisors LP279,817$2.11M0.0%-10.7%0.491%
11/12/2025 Caz Investments LP5,000$38K0.1%-33.3%0.009%
Gold majors have a big problem (Ad)

Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet production stayed at 5.9 million ounces, unchanged from 2020. Newmont, Barrick and Agnico all face the same reserve shortage, pushing majors toward acquiring smaller producing miners. Recent deals show the pattern: Rupert Resources jumped 67 percent and G2 Goldfields jumped 79 percent the day their buyouts were announced. Analyst Garrett Goggin has identified four junior miners he believes are next on the shopping list.tc pixel

See the four junior gold miners flagged as potential buyout targets
11/12/2025 Intech Investment Management LLC14,155$107K0.0%-28.0%0.025%
11/10/2025 Palumbo Wealth Management LLC52,081$392K0.1%-14.0%0.091%
11/10/2025 China Universal Asset Management Co. Ltd.34,982$263K0.0%+206.8%0.061%
11/7/2025Vanguard Group Inc.1,443,701$10.87M0.0%-1.9%2.535%
11/7/2025 JPMorgan Chase & Co.23,221$175K0.0%+26.7%0.041%
11/6/2025 Rhumbline Advisers46,334$349K0.0%-4.1%0.081%
8/15/2025 Caz Investments LP7,500$25K0.1%-50.0%0.013%
8/15/2025 Bridgeway Capital Management LLC188,200$634K0.0%+65.4%0.330%
8/15/2025 Bank of America Corp DE24,625$83K0.0%+11.1%0.043%
8/14/2025 MPM Bioimpact LLC555,187$1.87M0.3%-1.4%0.975%


DSGN Institutional Ownership - Frequently Asked Questions

During the previous two years, 98 institutional investors and hedge funds held shares of Design Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($38.49M), Trails Edge Capital Partners LP ($28.96M), Frazier Life Sciences Management L.P. ($26.19M), Logos Global Management LP ($23.45M), Baker BROS. Advisors LP ($20.95M), Vivo Capital LLC ($15.13M), and Almitas Capital LLC ($14.86M).Learn more on Design Therapeutics' institutional investors.

56.64% of Design Therapeutics' stock is owned by institutional investors. Learn more on DSGN's institutional investor holdings.

Of the 85 institutional investors that purchased Design Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($2.66M), Frazier Life Sciences Management L.P. ($2.57M), Trails Edge Capital Partners LP ($2.00M), Vivo Capital LLC ($1.61M), RA Capital Management L.P. ($1.46M), Almitas Capital LLC ($1.16M), and Driehaus Capital Management LLC ($913.40K).

Institutional investors have bought a total of 14,133,717 shares in the last 24 months. This purchase volume represents approximately $173.48M in transactions.

Of the 22 institutional investors that sold Design Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Frazier Life Sciences Management L.P. ($1.43M), Logos Global Management LP ($1.16M), Citadel Advisors LLC ($286.77K), Woodline Partners LP ($164.83K), Bridgeway Capital Management LLC ($109.70K), Susquehanna International Group LLP ($37.15K), and Dimensional Fund Advisors LP ($33.55K).

Institutional investors have sold a total of 3,360,645 shares in the last 24 months. This volume of shares sold represents approximately $30.42M in transactions.



Institutional ownership data for NASDAQ:DSGN is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/24/2026. New 13F filings are added each quarter as they're published.
From Our Partners